Jérémie Guedj

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu et al. · Science · 2020 · 2.4K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Daouda Sissoko, Cédric Laouenan, Elin Folkesson et al. · PLoS Medicine · 2016 · 486 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras et al. · Nature · 2020 · 361 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

Jérémie Guedj, Harel Dahari, Libin Rong et al. · Proceedings of the National Academy of Sciences · 2013 · 342 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17